Sponsor Dossier
Viatris
Sponsor Dossier for Viatris. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACNATAC
- Brand: AERON
- Brand: AMIRA
- Brand: ANPEC
- Brand: ASPALGIN
- Brand: ASPECILLIN VK
- Brand: AURORIX
- Brand: BECONASE
- Device (sponsor): Lubricant, eye
- Device (sponsor): Oral/enteral medicine medicated administration kit, reusable
- Device (sponsor): Spoon, medicine, reusable
About
Viatris is an Australian Private Company with ABN 29601608771, registered in NSW and currently active. The company was previously known as Mylan Health and Mylan EPD before adopting the Viatris name in 2021.
Portfolio
Viatris has 78 brands on the ARTG, of which 68 are indexable and 65 carry a Product Information document. 54 brands are PBS-listed, 10 have a PBAC outcome on record, and 8 have an AusPAR on record. Notable brands include ACNATAC, AERON, AMIRA, ANPEC, ASPALGIN, ASPECILLIN VK, AURORIX, BECONASE, BETAHISTINE VIATRIS, BIMTOP, BRUFEN®, CARAFATE.
Therapeutic focus
— Cardiology: 21 brands — Infectious Disease: 9 brands — Psychiatry: 9 brands — Gastroenterology: 7 brands — Pain Management: 6 brands — Neurology: 6 brands — Ophthalmology: 6 brands — Respiratory: 5 brands — Oncology: 3 brands — Dermatology: 2 brands — Reproductive Health: 1 brand — Hepatology: 1 brand — Renal: 1 brand — Musculoskeletal: 1 brand
PBS footprint
54 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-09-01, across 10 brands with a PBAC outcome on record. The latest AusPAR is 2022-03-28, across 8 brands with an AusPAR on record.